Abstract
Thank you, Dr McDonagh, for your careful review of our study. The discrepancies between Fig 1 and Table 3 had textual description that was regrettably cut during our internal review cycle which, hopefully, I can reconcile now. 1. 1. Figure 1 has 138 data points, of which 52 (38%), 45 (33%), and 41 (30%) were in the high-risk (H), moderate-risk (M), and low-risk (L) categories at the first 24 hours. 2. Of 152 patients, 2 withdrew, 12 had no unbound bilirubin (UB), 9 had no Scatchard plot data, and 24 had poor primary site …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
